Terms: = Gastric cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
39 results:
1. Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
Wei C; Ma Y; Wang F; Chen Y; Liao Y; Zhao B; Zhao Q; Tang D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15561-15572. PubMed ID: 37648811
[TBL] [Abstract] [Full Text] [Related]
2. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
Lu G; Wang X; Cheng M; Wang S; Ma K
Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of prognostic autophagy-related genes associated with immune microenvironment in human gastric cancer.
Tian R; Sun Y; Han X; Wang J; Gu H; Wang W; Liang L
Aging (Albany NY); 2022 Sep; 14(18):7617-7634. PubMed ID: 36173625
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
[TBL] [Abstract] [Full Text] [Related]
5. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract] [Full Text] [Related]
6. Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following
Raderer M; Kiesewetter B; Mayerhoefer ME
Expert Rev Hematol; 2022 Jul; 15(7):565-571. PubMed ID: 35695746
[TBL] [Abstract] [Full Text] [Related]
7. The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/cxcr4 Pathway.
Sánchez-Sánchez AV; García-España A; Sánchez-Gómez P; Font-de-Mora J; Merino M; Mullor JL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638956
[TBL] [Abstract] [Full Text] [Related]
8. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract] [Full Text] [Related]
9. Synthesis and Therapeutic Potential of Nanoceria against cancer: An Update.
Zahra D; Javaid A; Iqbal M; Akbar I; Ashfaq UA
Crit Rev Ther Drug Carrier Syst; 2021; 38(5):1-26. PubMed ID: 34375511
[TBL] [Abstract] [Full Text] [Related]
10. Precise Targeting Therapy of Orthotopic gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH-Sensitive Nano Platform.
Wang Q; Tian Y; Liu L; Chen C; Zhang W; Wang L; Guo Q; Ding L; Fu H; Song H; Shi J; Duan Y
Adv Healthc Mater; 2021 Oct; 10(20):e2100966. PubMed ID: 34363350
[TBL] [Abstract] [Full Text] [Related]
11. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract] [Full Text] [Related]
12. Identification and Validation of the Immune Regulator cxcr4 as a Novel Promising Target for gastric cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of trastuzumab combined with SOX or IP chemotherapy regimen in the treatment of advanced gastric cancer.
Xu D; Zhang Z; Zhang S; Fang X; Wang L; Li Q
J BUON; 2021; 26(3):932-939. PubMed ID: 34268956
[TBL] [Abstract] [Full Text] [Related]
14. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/cxcr4 axis by regulating autophagy in gastric cancer.
Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
[TBL] [Abstract] [Full Text] [Related]
15. Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer.
Zhang S; Li Z; Dong H; Wu P; Liu Y; Guo T; Li C; Wang S; Qu X; Liu Y; Che X; Xu L
Sci Prog; 2021; 104(1):36850421997286. PubMed ID: 33661721
[TBL] [Abstract] [Full Text] [Related]
16. The evolution of surgical treatment for gastrointestinal cancers.
Maehara Y; Soejima Y; Yoshizumi T; Kawahara N; Oki E; Saeki H; Akahoshi T; Ikegami T; Yamashita YI; Furuyama T; Sugimachi K; Harada N; Tagawa T; Harimoto N; Itoh S; Sonoda H; Ando K; Nakashima Y; Nagao Y; Yamashita N; Kasagi Y; Yukaya T; Kurihara T; Tsutsumi R; Takamori S; Sasaki S; Ikeda T; Yonemitsu Y; Fukuhara T; Kitao H; Iimori M; Kataoka Y; Wakasa T; Suzuki M; Teraishi K; Yoshida Y; Mori M
Int J Clin Oncol; 2019 Nov; 24(11):1333-1349. PubMed ID: 31522313
[TBL] [Abstract] [Full Text] [Related]
17. Somatostatin and chemokine cxcr4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
Kajtazi Y; Kaemmerer D; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2481-2493. PubMed ID: 31451931
[TBL] [Abstract] [Full Text] [Related]
18. Altered Expression of CD44, SIRT1, cxcr4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel treatment.
Motamedi M; Razmkhah F; Rezakhani L; Ghasemi S
J Gastrointest Cancer; 2020 Jun; 51(2):520-526. PubMed ID: 31273630
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of CXCL12/cxcr4 axis as a potential targeted therapy of advanced gastric carcinoma.
Xue LJ; Mao XB; Ren LL; Chu XY
Cancer Med; 2017 Jun; 6(6):1424-1436. PubMed ID: 28544785
[TBL] [Abstract] [Full Text] [Related]
20. SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-cxcr4-dependent manner.
Qiao J; Liu Z; Yang C; Gu L; Deng D
Oncotarget; 2016 Jul; 7(29):46088-46099. PubMed ID: 27323859
[TBL] [Abstract] [Full Text] [Related]
[Next]
